These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6732445)

  • 1. Availability of metoclopramide in vitro and in vivo.
    Vergin H; Strobel K; Grätzel von Grätz J
    Arch Pharm (Weinheim); 1984 Feb; 317(2):185-8. PubMed ID: 6732445
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bioavailability of metoclopramide with special reference to relevant literature data].
    Berner G; Emschermann B; Gladtke E; Haase W; Leuschner F; Vögtle-Junkert U; Wagener HH
    Arzneimittelforschung; 1982; 32(2):169-73. PubMed ID: 7199924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioavailability of metoclopramide in soft-gel capsules and tablets in healthy volunteers].
    Rapelli S
    Clin Ter; 1986 Nov; 119(3):219-25. PubMed ID: 3802734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bioavailability of metoclopramide in a sustained-release preparation].
    Berner G; Leuschner F; Wagener HH; Becker A
    Arzneimittelforschung; 1984; 34(5):637-9. PubMed ID: 6540582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics, bioequivalence and bioavailability of different formulations of metoclopramide in man.
    Block W; Pingoud A; Khan M; Kjellerup P
    Arzneimittelforschung; 1981; 31(6):1041-5. PubMed ID: 7196237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method.
    Randale SA; Dabhi CS; Tekade AR; Belgamwar VS; Gattani SG; Surana SJ
    Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):443-8. PubMed ID: 20410620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro dissolution and urinary excretion study of metoclopramide tablets.
    Quiroga PA; Bustillo PM; Volonté MG
    Biopharm Drug Dispos; 1998 Oct; 19(7):479-82. PubMed ID: 9818715
    [No Abstract]   [Full Text] [Related]  

  • 8. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
    Kasliwal N; Negi JS; Jugran V; Jain R
    Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of metoclopramide from hydrophobic matrix tablets. influence of hydrodynamic conditions on kinetic release parameters.
    Frutos P; Pabón C; Lastres JL; Frutos G
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1267-71. PubMed ID: 11605652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of metoclopramide.
    Bateman DN; Davies DS
    Lancet; 1979 Jan; 1(8108):166. PubMed ID: 84196
    [No Abstract]   [Full Text] [Related]  

  • 11. Biowaiver monographs for immediate release solid oral dosage forms: metoclopramide hydrochloride.
    Stosik AG; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Dressman JB; Barends DM
    J Pharm Sci; 2008 Sep; 97(9):3700-8. PubMed ID: 18271037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of powdered whole grapefruit and metoclopramide on the pharmacokinetics of cyclosporine in dogs.
    Radwanski NE; Cerundolo R; Shofer FS; Hanley MJ; Court MH
    Am J Vet Res; 2011 May; 72(5):687-93. PubMed ID: 21529222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioavailability of high-dose metoclopramide.
    Taylor WB; Bateman DN
    Eur J Clin Pharmacol; 1986; 31(1):41-4. PubMed ID: 3780825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of single doses of metoclopramide in renal failure.
    Bateman DN; Gokal R; Dodd TR; Blain PG
    Eur J Clin Pharmacol; 1981; 19(6):437-41. PubMed ID: 7250177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.
    Citron ML; Reynolds JR; Kalra J; Kay BG; Nathan KA; Jaffe ND; Miller FR
    Cancer Treat Rep; 1987 Mar; 71(3):317-9. PubMed ID: 3815397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of metoclopramide in man with observations in the dog.
    Bateman DN; Kahn C; Davies DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of the correlation between in vitro release and in vivo bioavailability of two aminophylline slow-release tablets.
    Lin SY; Kao YH; Chang HN
    J Pharm Sci; 1990 Apr; 79(4):326-30. PubMed ID: 2352144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of metoclopramide.
    Bateman DN
    Clin Pharmacokinet; 1983; 8(6):523-9. PubMed ID: 6360466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
    Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
    Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate.
    Skoug JW; Borin MT; Fleishaker JC; Cooper AM
    Pharm Res; 1991 Dec; 8(12):1482-8. PubMed ID: 1808610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.